Hennessy Balanced Fund Investor Class HBFBX

Medalist Rating as of | See Hennessy Investment Hub
  • NAV / 1-Day Return 13.40  /  −0.07 %
  • Total Assets 13.7M
  • Adj. Expense Ratio
    1.880%
  • Expense Ratio 1.880%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Moderately Conservative Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity —
  • Status Open
  • TTM Yield 1.64%
  • Turnover 39%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:53 AM GMT+0

Morningstar’s Analysis HBFBX

Will HBFBX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Hennessy Balanced Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HBFBX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 44.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United States Treasury Bills 0%

14.30 2M
Government

United States Treasury Bills 0%

13.71 2M
Government

United States Treasury Bills 0%

12.60 2M
Government

United States Treasury Bills 0%

7.82 1M
Government

Merck & Co Inc

6.02 828,825
Healthcare

Coca-Cola Co

5.11 702,986
Consumer Defensive

Amgen Inc

5.00 688,028
Healthcare

UnitedHealth Group Inc

4.98 685,790
Healthcare

Procter & Gamble Co

4.58 630,552
Consumer Defensive

Chevron Corp

4.57 629,888
Energy

Sponsor Center